资讯
Testicular Cancer Tumor Markers and Their Role in Diagnosis and Treatment. Medically reviewed by Darragh O'Carroll, MD — Written by Daniel Yetman on May 1, 2023. Tumor markers; ...
Serum tumor markers play a more critical role in testicular germ cell tumor management than in any other solid organ malignancy. Here, Barlow and colleagues discuss how the serum levels of AFP ...
The authors identified 4,742 cases of testicular cancer from the US population-based SEER database and evaluated the use of the tumor markers α-fetoprotein (AFP), human chorionic gonadotropin ...
March 27, 2008 — Within the Surveillance, Epidemiology, and End Results (SEER) registry, there is substantial variation in tumor-marker reporting for testis cancer, according to an analysis ...
Tumor markers such as Alpha Feto Protein (AFP) and Human Chorio Gonadotropin (HCG) help in the diagnosis and prognosis of testicular cancer.
Testicular Cancer Tumor Markers and Their Role in Diagnosis and Treatment. Tumor markers help doctors diagnose testicular cancer, determine treatment, and monitor how well that treatment is working.
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results. Research is still underway to identify specific markers for different types of cancers.
Serum-based tumor markers, which are one indicator of the presence of cancer cells, are helpful in several aspects of the care of patients with testis cancer, including diagnosis, prognostication ...
More genetic markers for inherited testicular cancer identified. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2021 / 07 / 210729083424.htm ...
A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers have found. The tumor markers can show presence or absence of disease.
Tumor markers are substances that can often be detected in higher-than-normal amounts in the blood, urine, or body tissues of some patients with certain types of cancer. Tumor markers are ...
Pant-Purohit, M, Brames, M, Abonour, R, et al. Tumor marker rise during second course high dose chemotherapy in recurrent testicular cancer: outcome analysis. J Bone Marrow Res 2013;1:118-118 Crossref ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果